In the News: Manali Mukherjee on long COVID

A COVID-19 survivor herself, the McMaster researcher has been studying - and experiencing - its lingering effects.

By Andrea Lawson April 5, 2022

A woman smiling at the camera
A COVID-19 survivor herself, researcher Manali Mukherjee has been studying – and experiencing – its lingering effects.

Expert Featured In This Story

Manali Mukherjee
Manali Mukherjee

Associate Professor

See Profile

It’s been more than a year since immunologist Manali Mukherjee was infected with COVID-19, but she is still waiting for her life to return to normal.

Her concentration, memory, and ability to multitask have all been impacted. She’s one of hundreds of thousands of Canadians dealing with long COVID, which can show up as a variety of cognitive and physical issues and can last for months after infection.

Despite the slog she feels day-to-day, the assistant professor in McMasters department of medicine is optimistic, noting that will proper care most people with long COVID will eventually recover.

“People are getting better at six months, 12 months. Several studies have shown, from patient-reported outcomes, that just because you have long COVID symptoms, it doesn’t mean you will have them for life,” she tells the Toronto Star.

Mukherjee is also fighting long COVID in her professional life, leading a team of McMaster researchers studying long COVID and what causes it.

Long COVID is an issue that’s been discussed at length, and sometimes in dire terms, because of the sheer number of people suffering. But there’s no need to be overly alarmed, Mukherjee says.

Not only to most people get better, this is not the first time people have experienced post-viral syndromes like this, she notes. It’s happened to people infected with other coronaviruses and even the flu.

“The government is aware of it, the medical community is aware of it, and there is massive research going on.”

She is confident we will get through it and the large number of people suffering will get better.

“We have gone through worse, our forefathers have gone through worse. Now, at least we have advanced medical technology. All we’ll have to do is look forward.”

Three smiling researchers stand together in a lab.

McMaster researchers use friendly viruses to tackle inflammatory bowel disease

Researchers from Health Sciences and Engineering worked together on a targeted approach using bacteriophages to disarm harmful microbes without disrupting the broader gut ecosystem.
A racially diverse group of people sitting in a sunlit room.

Analysis: The ethics of being left out of health research

Research ethics boards must not become so preoccupied with the potential harm of participation that they overlook the certain harm of exclusion, write Sonia Anand, Gina Ogilvie and Vanessa Watts.
gloved hands reach into a sterile lab environment to work with chemicals.

McMaster and U of T announce early-stage life sciences venture fund with Genesys Capital 

The support for startups in Ontario promises to address health-care challenges, boost the Canadian economy and improve patient care.